Showing results (221-230 of 472) with videos related to

Sort By:
Pageof 48
BMC Medicine|August 13, 2021
SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling studySimon R Procter, Kaja Abbas, Stefan Flasche, et al.
Vaccine|January 26, 2010
Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluationMarc Baguelin, Albert Jan Van Hoek, Mark Jit, et al.
Vaccine|March 14, 2026
The potential global health impact and net monetary benefit of programmatic use of improved influenza vaccines: a mathematical modelling studyLucy Goodfellow, Adam Soble, Stefano Malvolti, et al.
Vaccine|April 29, 2015
Estimating costs of care for meningitis infections in low- and middle-income countriesAllison Portnoy, Mark Jit, Jeremy Lauer, et al.
Vaccine|June 27, 2020
The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two modelsRanju Baral, Xiao Li, Lander Willem, et al.
BMJ Quality & Safety|June 5, 2014
Moving improvement research closer to practice: the Researcher-in-Residence modelMartin Marshall, Christina Pagel, Catherine French, et al.
Lancet (London, England)|September 29, 2009
Estimation of potential effects of improved community-based drug provision, to augment health-facility strengthening, on maternal mortality due to post-partum haemorrhage and sepsis in sub-Saharan Africa: an equity-effectiveness modelChristina Pagel, Sonia Lewycka, Tim Colbourn, et al.
Vaccine|March 27, 2018
A bibliometric analysis of systematic reviews on vaccines and immunisationSilke Fernandes, Mark Jit, Fiammetta Bozzani, et al.
BMC Medicine|March 9, 2022
Differential health impact of intervention programs for time-varying disease risk: a measles vaccination modeling studyAllison Portnoy, Yuli Lily Hsieh, Kaja Abbas, et al.
Cost Effectiveness and Resource Allocation : C/E|May 15, 2023
What are economic costs and when should they be used in health economic studies?Hugo C Turner, Frank G Sandmann, Laura E Downey, et al.
Pageof 48